Drugs / Aastrom Tissue Repair Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00424567 | Oct 2003 → Jun 2007 | bone disorder | Vericel Corporation | Terminated | No outcome recorded Stop: Business |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aastrom Tissue Repair Cells | “Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.” NCT00424567 ↗ |
| Known as | Aastrom TRC | “The purpose of this multi-center study is to obtain clinical data to substantiate that Aastrom TRC autologous bone marrow cells will regenerate bone in patients with...” NCT00424567 ↗ |
| Modality | Cell therapy | “Aastrom TRC autologous bone marrow cells will regenerate bone in patients with established (appendicular skeletal) non union fractures” NCT00424567 ↗ |
| Route | Other | “The processed cells will be mixed with commercially available bone matrix during surgery and placed in the area of the fracture.” NCT00424567 ↗ |